Original Research
Published on 15 Sep 2022
A bibliometric analysis of autophagy in atherosclerosis from 2012 to 2021
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.977870
- 4,639 views
- 6 citations
Type at least 3 characters
1,204 articles
Articles
Review
Published on 14 Sep 2022
The synergistic compatibility mechanisms of fuzi against chronic heart failure in animals: A systematic review and meta-analysis
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.954253
- 4,451 views
- 5 citations
Review
Published on 13 Sep 2022
Research progress in endothelial cell injury and repair
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.997272
- 9,940 views
- 13 citations
Original Research
Published on 13 Sep 2022
Effects and mechanisms of 6-hydroxykaempferol 3,6-di-O-glucoside-7-O-glucuronide from Safflower on endothelial injury in vitro and on thrombosis in vivo
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.974216
- 2,762 views
- 2 citations
Review
Published on 12 Sep 2022
Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.999404
- 10,410 views
- 26 citations
Original Research
Published on 09 Sep 2022
QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.981206
- 5,816 views
- 10 citations
Review
Published on 09 Sep 2022
Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1000316
- 3,302 views
- 6 citations
Original Research
Published on 08 Sep 2022
ELA-11 protects the heart against oxidative stress injury induced apoptosis through ERK/MAPK and PI3K/AKT signaling pathways
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.873614
- 5,325 views
- 8 citations
Review
Published on 07 Sep 2022
Sex difference in circulating PCSK9 and its clinical implications
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.953845
- 4,990 views
- 17 citations
Mini Review
Published on 06 Sep 2022
Advances in lncRNAs from stem cell-derived exosome for the treatment of cardiovascular diseases
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.986683
- 3,857 views
- 13 citations
Original Research
Published on 02 Sep 2022
Protective effects of mitochondrial fission inhibition on ox-LDL induced VSMC foaming via metabolic reprogramming
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.970151
- 2,750 views
- 6 citations
Original Research
Published on 02 Sep 2022
Effects of the peripheral CB1 receptor antagonist JD5037 in mono— and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.965613
- 4,178 views
- 4 citations
Original Research
Published on 01 Sep 2022
Deciphering the combination mechanisms of Gualou–Xiebai herb pair against atherosclerosis by network pharmacology and HPLC-Q-TOF-MS technology
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.941400
- 4,689 views
- 11 citations
Original Research
Published on 01 Sep 2022
Investigation of the pharmacological effect and mechanism of mountain-cultivated ginseng and garden ginseng in cardiovascular diseases based on network pharmacology and zebrafish experiments
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.920979
- 3,068 views
- 4 citations
Review
Published on 01 Sep 2022
Role of resveratrol in inhibiting pathological cardiac remodeling
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.924473
- 8,265 views
- 19 citations
Review
Published on 31 Aug 2022
Neuregulin-1, a potential therapeutic target for cardiac repair
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.945206
- 8,746 views
- 25 citations